{
    "eid": "2-s2.0-85029817701",
    "title": "Panobinostat plus bortezomib and dexamethasone: impact of dose intensity and administration frequency on safety in the PANORAMA 1 trial",
    "cover-date": "2017-10-01",
    "subject-areas": [
        {
            "$": "Hematology",
            "@code": "2720"
        }
    ],
    "keywords": [
        "deacetylase inhibitor",
        "dose intensity",
        "multiple myeloma",
        "panobinostat",
        "safety"
    ],
    "authors": [
        "Jes\u00fas F. San-Miguel"
    ],
    "citedby-count": 17,
    "ref-count": 19,
    "ref-list": [
        "Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges",
        "Subcutaneous versus intravenous bortezomib: Efficiency practice variables and patient preferences",
        "Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor - Induced thrombocytopenia",
        "Aggresome induction by proteasome inhibitor bortezomib and \u03b1-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells",
        "Rapid recovery from panobinostat (LBH589)-induced thrombocytopenia in mice involves a rebound effect of bone marrow megakaryocytes",
        "Mechanism of action of proteasome inhibitors and deacetylase inhibitors and the biological basis of synergy in multiple myeloma",
        "Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma",
        "Clinical course of patients with relapsed multiple myeloma",
        "Improved survival in multiple myeloma and the impact of novel therapies",
        "Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study",
        "Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma",
        "Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: A randomised trial",
        "Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma",
        "Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: A randomised, phase 3, non-inferiority study",
        "In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma",
        "Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by prior treatment",
        "Epidemiology: An Introduction",
        "Effects of lenalidomide and dexamethasone treatment duration on survival in patients with relapsed or refractory multiple myeloma treated with lenalidomide and dexamethasone",
        "Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: A multicentre, randomised, double-blind phase 3 trial"
    ],
    "affiliation": [
        {
            "affiliation-city": "Basel",
            "affilname": "Novartis International AG",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Seongnam",
            "affilname": "Gachon University",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Siriraj Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Warsaw",
            "affilname": "Medical University of Warsaw",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Alexandria",
            "affilname": "Alexandria University",
            "affiliation-country": "Egypt"
        },
        {
            "affiliation-city": "Athens",
            "affilname": "National and Kapodistrian University of Athens",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Nantes",
            "affilname": "CHU de Nantes",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Seoul National University Hospital",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Pamplona",
            "affilname": "Cl\u00ednica Universidad de Navarra",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Shanghai",
            "affilname": "Changzheng Hospital",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Wurzburg",
            "affilname": "Julius-Maximilians-Universit\u00e4t W\u00fcrzburg",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Ankara",
            "affilname": "Ankara \u00dcniversitesi",
            "affiliation-country": "Turkey"
        },
        {
            "affiliation-city": "Hamburg",
            "affilname": "Asklepios Klinik Altona",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Kiel",
            "affilname": "Universit\u00e4tsklinikum Schleswig-Holstein Campus Kiel",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Boston",
            "affilname": "Harvard Medical School",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Atlanta",
            "affilname": "Emory University",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Florence Binlich",
        "Janssen-Cilag and Novartis",
        "Novartis",
        "Novartis Pharmaceuticals Corporation",
        "Cilag"
    ]
}